A detailed history of Laurion Capital Management LP transactions in Pfizer Inc stock. As of the latest transaction made, Laurion Capital Management LP holds 900,000 shares of PFE stock, worth $25.2 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
900,000
Previous 2,445,346 63.2%
Holding current value
$25.2 Million
Previous $70.4 Million 64.52%
% of portfolio
0.22%
Previous 0.62%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $40 Million - $45.9 Million
-1,545,346 Reduced 63.2%
900,000 $25 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $52.9 Million - $68.8 Million
2,026,178 Added 483.38%
2,445,346 $70.4 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $12.4 Million - $14.3 Million
342,984 Added 450.2%
419,168 $15.4 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $454,639 - $591,873
11,542 Added 17.86%
76,184 $3.11 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $2.7 Million - $3.52 Million
64,642 New
64,642 $3.31 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $481,911 - $571,395
10,357 Added 246.6%
14,557 $763,000
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $192,150 - $238,098
4,200 New
4,200 $217,000
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $3.98 Million - $5.11 Million
-101,353 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $1.95 Million - $2.21 Million
54,206 Added 114.97%
101,353 $3.97 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $1.09 Million - $1.23 Million
32,514 Added 222.2%
47,147 $1.71 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $7.89 Million - $10 Million
-235,715 Reduced 94.15%
14,633 $539,000
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $5.47 Million - $6.42 Million
-172,406 Reduced 40.78%
250,348 $9.19 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $12.7 Million - $15.4 Million
422,654 Added 422654.0%
422,754 $13.8 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $3,249 - $4,213
100 New
100 $4,000
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $848,700 - $932,438
-22,632 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $719,696 - $820,532
18,708 Added 476.76%
22,632 $988,000
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $4.18 Million - $5.07 Million
-121,359 Reduced 96.87%
3,924 $173,000
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $2.18 Million - $2.33 Million
-66,228 Reduced 34.58%
125,283 $4.55 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $1.88 Million - $2.18 Million
-58,889 Reduced 23.52%
191,511 $6.8 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $2.64 Million - $2.8 Million
79,416 Added 46.45%
250,400 $9.07 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $5.3 Million - $5.84 Million
170,984
170,984 $6.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.